Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kevin Crowley
AddedMar 31, 2024
UpdatedMay 31, 2026
Kevin Crowley

Kevin Crowley

Board Member, Cara Therapeutics

CrunchbaseLinkedIn

Kevin Crowley's Career

Cara Therapeutics
Cara Therapeutics

Stamford, CT, US

Board Member· Board
Intelligent Clearing Network
Intelligent Clearing Network

North Haven, CT, US

Board Member· Board
Affinimark Technologies
Affinimark Technologies

New Haven, CT, US

Board Member· Board
Arcanatura
Arcanatura

Groton, CT, US

Board Member· Board
CaroGen
CaroGen

Farmington, NM, US

Board Member· Board
Oxford Performance Materials
Oxford Performance Materials

South Windsor, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kevin Crowley's Career

Cara Therapeutics
Cara Therapeutics
Public$517.2M1062004Stamford, CT, US
Board Member· Board

Leadership at Cara Therapeutics

Helen M. BoudreauHelen M. BoudreauBoard Member
Derek ChalmersDerek ChalmersBoard Member
Martin VogelbaumMartin VogelbaumBoard Member
Susan ShiffSusan ShiffBoard Member
Chris PosnerChris PosnerBoard Member
Jeff IvesJeff IvesBoard Member

Similar to Cara Therapeutics

Lyra TherapeuticsLyra TherapeuticsWatertown, MA, USDrugs, Therapeuticsest. 2014Lyra TherapeuticsWatertown, MA, US · est. 2014

Lyra Therapeutics, Inc.: A clinical-stage biotech firm innovating localized treatments for chronic rhinosinusitis.

Public · $264.1M66
CarthroniXCarthroniXLos Angeles, CA, USPharmaceuticals, Therapeuticsest. 2015CarthroniXLos Angeles, CA, US · est. 2015

CarthroniX: A pharmaceutical company providing innovative therapy and skin regeneration solutions.

Seed · $2.3M8
Carmot TherapeuticsCarmot TherapeuticsBerkeley, CA, USDrug Developmentest. 2008Carmot TherapeuticsBerkeley, CA, US · est. 2008

San Francisco-based Carmot Therapeutics develops medicines for inflammatory, metabolic, and neurodegenerative diseases.

Series E · $384.8M72
NeurocarrusNeurocarrusMonterey, CA, USDrug Deliveryest. 2015NeurocarrusMonterey, CA, US · est. 2015

Neurocarrus: Innovating non-addictive, pain-disrupting drug delivery technology.

Seed · $100k8
Intelligent Clearing Network
Intelligent Clearing Network
Pre-Seed$2.6M92008North Haven, CT, US
Board Member· Board

Leadership at Intelligent Clearing Network

Brian SchulteBrian SchulteCo-Founder
Rich ThibedeauRich ThibedeauCo-Founder

Similar to Intelligent Clearing Network

coupondcoupondNew York City, NY, USCoupons, Loyalty Softwareest. 2020coupondNew York City, NY, US · est. 2020

AI-powered loyalty software offering the world's first universal coupon system.

Seed · $2.5M6
Coupon WalletCoupon WalletSterling Heights, MI, USCoupon, Marketingest. 2012Coupon WalletSterling Heights, MI, US · est. 2012

Coupon Wallet, a disruptive tech platform, revolutionizes coupon marketing by providing a seamless digital solution for coupon distribution, tracking, and redemption.

Angel · $150k6
Intelligent Currency Validation NetworkIntelligent Currency Validation NetworkTimonium, MD, USCash Tracking, Check Validationest. 2001Intelligent Currency Validation NetworkTimonium, MD, US · est. 2001

Maryland-based ICVN, Inc. provides global network solutions for cash tracking and check validation, combating illegal activities.

Angel · $144k30
Wildfire SystemsWildfire SystemsSolana Beach, CA, USCashback, Couponsest. 2017Wildfire SystemsSolana Beach, CA, US · est. 2017

Wildfire Systems: Monetizing ecommerce with white-label cashback and coupon services.

Series B · $17.5M68
Affinimark Technologies
Affinimark Technologies
Seed$2.9M82007New Haven, CT, US
Board Member· Board

Leadership at Affinimark Technologies

Daniel WagnerDaniel WagnerBoard Member
Eleanor TandlerEleanor TandlerCEO
Harry H. PennerHarry H. PennerBoard Member
Vincent PieriboneVincent PieriboneBoard Member
Arcanatura
Arcanatura
Seed$180k72011Groton, CT, US
Board Member· Board

Similar to Arcanatura

Veterinary PrimeVeterinary PrimeNew York City, NY, USPet Food, Pet Nutritionest. 2015Veterinary PrimeNew York City, NY, US · est. 2015

NYC-based food & drink company creating premium pet nutrition products exclusively for vets.

Series A · $4.3M5
Orangedog0485Orangedog0485San Francisco, CA, USPet Products, Pet Wellnessest. 2015Orangedog0485San Francisco, CA, US · est. 2015

Promoting pet health and wellness, empowering pets and owners for optimal outdoor living.

Seed · $10k375
MySimplePetLabMySimplePetLabCentennial, CO, USPet Care, Pet Testingest. 2019MySimplePetLabCentennial, CO, US · est. 2019

MySimplePetLab: A distributed pet care provider offering comprehensive testing and results.

Seed · $9.7M18
ArcaeaArcaeaBoston, MA, USBeauty Products, Ingredientsest. 2021ArcaeaBoston, MA, US · est. 2021

Arcaea: Revolutionizing the beauty industry through innovative biotech product development.

Series A · $78M40
CaroGen
CaroGen
Public$11.3M302012Farmington, NM, US
Board Member· Board

Leadership at CaroGen

Bijan AlmassianBijan AlmassianCo-Founder
Valerian NakaarValerian NakaarCo-Founder

Similar to CaroGen

CargeneCargeneCambridge, MA, USDrug Development, Therapeuticsest. 2020CargeneCambridge, MA, US · est. 2020

Cargene: A bio-pharmaceutical firm innovating oligonucleotide therapies for cardiovascular and lung diseases.

Seed · $19.2M26
CodagenixCodagenixFarmingdale, NY, USVaccinesest. 2009CodagenixFarmingdale, NY, US · est. 2009

Codagenix Inc.: A US-based clinical-stage biotech firm developing vaccines for various viruses.

Series A · $65.6M42
CaraVan BiologixCaraVan BiologixAndover, NJ, USBiotechnology, Therapeuticsest. 2020CaraVan BiologixAndover, NJ, US · est. 2020

CaraVan Biologix: Pioneering life-saving CAR-T cell therapeutics in biotechnology.

Seed · $1.7M7
Carbon BiosciencesCarbon BiosciencesLexington, MA, USGene Therapyest. 2021Carbon BiosciencesLexington, MA, US · est. 2021

Carbon Biosciences: Advancing gene therapy potential with a unique, nature-tested parvovirus platform.

Series A · $38M45
Oxford Performance Materials
Oxford Performance Materials
Public$33.6M282000South Windsor, CT, US
Board Member· Board

Leadership at Oxford Performance Materials

Jordan DeFeliceJordan DeFeliceBoard Member
Severine Valdant ZygmontSeverine Valdant ZygmontBoard Member
Scott DeFeliceScott DeFeliceBoard Member
Paul MartinPaul MartinBoard Member

Similar to Oxford Performance Materials

New Ortho PolymersNew Ortho PolymersFarmington, CT, USBiotechnologyest. 2005New Ortho PolymersFarmington, CT, US · est. 2005

Innovative biotech company specializing in ortho polymers.

Seed · $250k6
Quantum OPSQuantum OPSFort Wayne, IN, USMedical Devicesest. 2010Quantum OPSFort Wayne, IN, US · est. 2010

QuantumOPS: Innovating orthopedic technology for superior clinical outcomes and responsive market solutions.

Series A · $1.1M7
Rapid TPCRapid TPCPittsburgh, PA, USManufacturingest. 2013Rapid TPCPittsburgh, PA, US · est. 2013

Rapid TPC: High-quality thermoplastic composite parts manufacturer for diverse industries.

Seed · $95k4
O2M TechnologiesO2M TechnologiesChicago, IL, USMedical Devicesest. 2017O2M TechnologiesChicago, IL, US · est. 2017

O2M Technologies, founded in 2017, develops oxygen imaging devices for cancer and regenerative medicine.

Pre-Seed · $1.2M6

Kevin Crowley's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Kevin Crowley

James BoyleJames BoyleFounder · YEI Innovation FundAndre SwanstonAndre SwanstonBoard Member · Connecticut InnovationsPeter LongoPeter LongoBoard Member · NovaTract SurgicalJeffrey SonnenfeldJeffrey SonnenfeldBoard Member · Lennar VenturesStephany SantosStephany SantosCo-Founder · University of ConnecticutCheryl GriséCheryl GriséBoard Member · Pultegroup